BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22134512)

  • 1. A phase III study of late course accelerated hyperfractionated radiotherapy versus conventionally fractionated radiotherapy in patients with nasopharyngeal carcinoma.
    Pan ZQ; He XY; Guo XM; Ye M; Zhang Z; He SQ; Liu TF
    Am J Clin Oncol; 2012 Dec; 35(6):600-5. PubMed ID: 22134512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late course accelerated hyperfractionated radiotherapy of nasopharyngeal carcinoma (LCAF).
    He XY; Liu TF; He SQ; Huan SL; Pan ZQ
    Radiother Oncol; 2007 Oct; 85(1):29-35. PubMed ID: 17889386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late course accelerated hyperfractionated radiotherapy plus concurrent chemotherapy for squamous cell carcinoma of the esophagus: a phase III randomized study.
    Zhao KL; Shi XH; Jiang GL; Yao WQ; Guo XM; Wu GD; Zhu LX
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1014-20. PubMed ID: 15990003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized controlled trial of conventional fraction and late course accelerated hyperfraction three-dimensional conformal radiotherapy for esophageal cancer.
    Wang JH; Lu XJ; Zhou J; Wang F
    Cell Biochem Biophys; 2012 Jan; 62(1):107-12. PubMed ID: 21858589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
    Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late-course accelerated hyperfractionated radiotherapy for localized esophageal carcinoma.
    Zhao KL; Shi XH; Jiang GL; Wang Y
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):123-9. PubMed ID: 15337547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment outcome of patients with stages I-II nasopharyngeal carcinoma after late course accelerated hyperfractionation radiotherapy alone.
    He X; Ye M; Guo X; Pan Z; Zhang Z; He S; Liu T
    Oral Oncol; 2012 Oct; 48(10):1058-1063. PubMed ID: 22658301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary results of a randomized study (NPC-9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma.
    Lee AW; Tung SY; Chan AT; Chappell R; Fu YT; Lu TX; Tan T; Chua DT; O'sullivan B; Xu SL; Pang ES; Sze WM; Leung TW; Kwan WH; Chan PT; Liu XF; Tan EH; Sham JS; Siu L; Lau WH
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):142-51. PubMed ID: 16904519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised trial of accelerated radiotherapy for localised invasive bladder cancer.
    Horwich A; Dearnaley D; Huddart R; Graham J; Bessell E; Mason M; Bliss J
    Radiother Oncol; 2005 Apr; 75(1):34-43. PubMed ID: 15878099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between continuous accelerated hyperfractionated and late-course accelerated hyperfractionated radiotherapy for esophageal carcinoma.
    Wang Y; Shi XH; He SQ; Yao WQ; Wang Y; Guo XM; Wu GD; Zhu LX; Liu TF
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):131-6. PubMed ID: 12182982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of a prospective randomised trial comparing conventional radiotherapy to split course bifractionated radiation therapy in patients with nasopharyngeal carcinoma.
    Daoud J; Toumi N; Siala W; Ghorbel A; Drira MM; Frikha M
    Radiother Oncol; 2007 Oct; 85(1):17-23. PubMed ID: 17343938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of late accelerated hyperfractionated conformal radiotherapy combined with capecitabine for esophageal carcinoma].
    Sheng W; Feng XZ; Han JQ
    Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):702-6. PubMed ID: 22340054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Simultaneous modulated accelerated radiation therapy in the treatment of nasopharyngeal cancer].
    Xie CY; Wu SX; Jin XC; Yu JY; Wang JH; Li WF; Zhang P
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2412-5. PubMed ID: 18036320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperfractionated radiotherapy in locally advanced nasopharyngeal cancer. An analysis of 43 consecutive patients.
    Jereczek-Fossa BA; Morra A; DeBraud F; Alterio D; Mazzetta C; Rocca A; Catalano G; Bianchi L; Pasetti M; Chiesa F; Bruschini R; Orecchia R
    Strahlenther Onkol; 2004 Jul; 180(7):425-33. PubMed ID: 15241530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial.
    Budach V; Stuschke M; Budach W; Baumann M; Geismar D; Grabenbauer G; Lammert I; Jahnke K; Stueben G; Herrmann T; Bamberg M; Wust P; Hinkelbein W; Wernecke KD
    J Clin Oncol; 2005 Feb; 23(6):1125-35. PubMed ID: 15718308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma].
    Zhao C; Han F; Lu LX; Huang SM; Lin CG; Deng XW; Lu TX; Cui NJ
    Ai Zheng; 2004 Nov; 23(11 Suppl):1532-7. PubMed ID: 15566674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized clinical trial on continuous 7-days-a-week postoperative radiotherapy for high-risk squamous cell head-and-neck cancer: a report on acute normal tissue reactions.
    Suwinski R; Bankowska-Wozniak M; Majewski W; Sowa A; Idasiak A; Ziolkowska E; Windorbska W; Tarnawski R; Skladowski K; Maciejewski B
    Radiother Oncol; 2005 Oct; 77(1):58-64. PubMed ID: 16157401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term efficacy of external radiotherapy plus intracavitary hyperfractionated brachytherapy on nasopharyngeal carcinoma].
    Lin SJ; Pan JJ; Wu JX; Han L; Pan CZ
    Ai Zheng; 2007 Feb; 26(2):208-11. PubMed ID: 17298755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.